These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 796642)

  • 1. Optimal dose of a thiazide diuretic.
    Carney S; Gillies AI; Morgan T
    Med J Aust; 1976 Oct; 2(18):692-3. PubMed ID: 796642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial potassium loss and hypokalaemia during chlorthalidone administration in patients with essential hypertension: the influence of dietary sodium restriction.
    Landmann-Suter R; Struyvenberg A
    Eur J Clin Invest; 1978 Jun; 8(3):155-64. PubMed ID: 28952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated systolic hypertension in the elderly. A placebo-controlled, dose-response evaluation of chlorthalidone.
    Morledge JH; Ettinger B; Aranda J; McBarron F; Barra P; Gorwit J; Davidov M
    J Am Geriatr Soc; 1986 Mar; 34(3):199-206. PubMed ID: 3512670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose.
    Materson BJ; Oster JR; Michael UF; Bolton SM; Burton ZC; Stambaugh JE; Morledge J
    Clin Pharmacol Ther; 1978 Aug; 24(2):192-8. PubMed ID: 354839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
    Carpentiere G; Marino S; Castello F
    Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum potassium mediate thiazide-induced diabetes.
    Shafi T; Appel LJ; Miller ER; Klag MJ; Parekh RS
    Hypertension; 2008 Dec; 52(6):1022-9. PubMed ID: 18981326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program.
    Franse LV; Pahor M; Di Bari M; Somes GW; Cushman WC; Applegate WB
    Hypertension; 2000 May; 35(5):1025-30. PubMed ID: 10818057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: a randomized study within a clinical trial.
    Grimm RH; Neaton JD; McDonald M; Case J; McGill E; Allen R; Bailey-Hoffman G; Kousch D; Childs J; Hulley SB
    Am Heart J; 1985 Apr; 109(4):858-64. PubMed ID: 3885701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis.
    Liang W; Ma H; Cao L; Yan W; Yang J
    J Cell Mol Med; 2017 Nov; 21(11):2634-2642. PubMed ID: 28631393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive.
    Pierini D; Anderson KV
    Ann Pharmacother; 2013 May; 47(5):694-703. PubMed ID: 23585646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrochlorothiazide versus chlorthalidone in the management of hypertension.
    Neff KM; Nawarskas JJ
    Cardiol Rev; 2010; 18(1):51-6. PubMed ID: 20010338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension.
    Bagatin J; Sardelić S; Pivac N; Polić S; Ljutic D; Rakic D; Naranca M; Bojić L; Kovacić Z; Rumboldt Z
    Int J Clin Pharmacol Res; 1998; 18(2):73-8. PubMed ID: 9675624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.
    Martins VM; Helal L; Ferrari F; Bottino LG; Fuchs SC; Fuchs FD
    Trials; 2019 Dec; 20(1):736. PubMed ID: 31843024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study.
    Agarwal R; Sinha AD; Pappas MK; Ammous F
    Am J Nephrol; 2014; 39(2):171-82. PubMed ID: 24526255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose diuretic therapy for hypertension.
    Moser M
    Clin Ther; 1986; 8(5):554-62. PubMed ID: 3768929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorthalidone treatment in patients with hypertension associated with hypokalaemia.
    Skerrett FD
    Br Med J (Clin Res Ed); 1985 Sep; 291(6496):642. PubMed ID: 3928064
    [No Abstract]   [Full Text] [Related]  

  • 17. The antihypertensive and biochemical effects of hydrochlorothiazide/amiloride (Moduretic) versus chlorthalidone.
    van Soeren F
    J Int Med Res; 1980; 8(2):132-5. PubMed ID: 6989682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diuretic-induced hypokalemia and altered renal function.
    Carney SL; Morgan TO
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):665-7. PubMed ID: 3546168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma renin activity does not predict the antihypertensive efficacy of chlorthalidone.
    Salvetti A; Pedrinelli R; Bartolomei G; Cagianelli MA; Cinotti G; Innocenti P; Loni C; Saba G; Saba P; Papi L
    Eur J Clin Pharmacol; 1987; 33(3):221-6. PubMed ID: 3319646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study.
    Dhalla IA; Gomes T; Yao Z; Nagge J; Persaud N; Hellings C; Mamdani MM; Juurlink DN
    Ann Intern Med; 2013 Mar; 158(6):447-55. PubMed ID: 23552325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.